We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
-3.62%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.27B
AUM Growth
+$1.03B
Cap. Flow
+$1.33B
Cap. Flow %
25.3%
Top 10 Hldgs %
33.76%
Holding
622
New
34
Increased
508
Reduced
35
Closed
25

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$87.7M
2
NVDA icon
NVIDIA
NVDA
+$78.5M
3
MSFT icon
Microsoft
MSFT
+$77.3M
4
AMZN icon
Amazon
AMZN
+$56M
5
META icon
Meta Platforms (Facebook)
META
+$35.6M

Top Sells

Rank Stock Value
1
PRIM icon
Primoris Services
PRIM
+$7.16M
2
FLR icon
Fluor
FLR
+$5.32M
3
FSS icon
Federal Signal
FSS
+$5.11M
4
ALLE icon
Allegion
ALLE
+$3.66M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.53M

Sector Composition

Rank Sector Weight
1 Technology 31.85%
2 Healthcare 10.37%
3 Communication Services 9.8%
4 Consumer Discretionary 9.65%
5 Financials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
576
Relay Therapeutics
RLAY
$4.38B
$233K ﹤0.01%
89,110
+24,455
+38% +$95.8K
OHI icon
577
Omega Healthcare
OHI
$13.8B
$231K ﹤0.01%
+6,075
New +$226K
ORIC icon
578
Oric Pharmaceuticals
ORIC
$1.42B
$228K ﹤0.01%
40,934
-4,542
-10% -$39.7K
LH icon
579
Labcorp
LH
$26.1B
$225K ﹤0.01%
967
+1
+0.1% +$243
DPZ icon
580
Domino's
DPZ
$11.8B
$222K ﹤0.01%
484
– –
FFIV icon
581
F5
FFIV
$23.4B
$220K ﹤0.01%
827
– –
EG icon
582
Everest Group
EG
$14B
$218K ﹤0.01%
601
– –
LAMR icon
583
Lamar Advertising Co
LAMR
$15.6B
$216K ﹤0.01%
+1,895
New +$231K
JAZZ icon
584
Jazz Pharmaceuticals
JAZZ
$16.1B
$208K ﹤0.01%
1,672
– –
DNLI icon
585
Denali Therapeutics
DNLI
$3.95B
$206K ﹤0.01%
+15,174
New +$291K
CUBE icon
586
CubeSmart
CUBE
$9.2B
$206K ﹤0.01%
+4,886
New +$204K
XENE icon
587
Xenon Pharmaceuticals
XENE
$6.11B
$205K ﹤0.01%
6,111
– –
RACE icon
588
Ferrari
RACE
$72.1B
$201K ﹤0.01%
+469
New +$211K
NTLA icon
589
Intellia Therapeutics
NTLA
$1.68B
$189K ﹤0.01%
26,537
-101,289
-79% -$1.02M
AGNC icon
590
AGNC Investment
AGNC
$12.9B
$185K ﹤0.01%
+19,340
New +$193K
ACAD icon
591
Acadia Pharmaceuticals
ACAD
$5.07B
$176K ﹤0.01%
10,596
– –
AUTL
592
Autolus Therapeutics
AUTL
$620M
$171K ﹤0.01%
+110,428
New +$224K
CELC icon
593
Celcuity
CELC
$4.3B
$158K ﹤0.01%
+15,619
New +$177K
RITM icon
594
Rithm Capital
RITM
$5.72B
$128K ﹤0.01%
+11,190
New +$129K
RCUS icon
595
Arcus Biosciences
RCUS
$3.66B
$120K ﹤0.01%
15,251
-6,982
-31% -$80.9K
TALK icon
596
Talkspace
TALK
$869M
$71.3K ﹤0.01%
27,834
+1,497
+6% +$4.66K
VYGR icon
597
Voyager Therapeutics
VYGR
$197M
$50.6K ﹤0.01%
14,960
– –
AEIS icon
598
Advanced Energy
AEIS
$13.1B
– –
-3,780
Closed -$437K
AGIO icon
599
Agios Pharmaceuticals
AGIO
$1.95B
– –
-25,735
Closed -$846K
AGX icon
600
Argan
AGX
$8.11B
– –
-1,920
Closed -$263K
21 22 23
24
25

Similar funds

NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

NEOS Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, NEOS Investment Management held 622 positions worth $5.27B, up 24% from $4.25B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

NEOS Investment Management deployed $1.33B of net new capital in Q1 2025, opening 34 new positions and adding to 508 existing holdings. Its largest new stake was OGE Energy: 73,034 shares worth $3.36M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $2.53M trimmed.

  • NEOS Investment Management's largest Q1 2025 buy was OGE Energy: 73,034 shares worth $3.36M.
  • NEOS Investment Management added most to Apple in Q1 2025, an estimated $87.7M increase.
  • NEOS Investment Management's biggest Q1 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.53M.
  • NEOS Investment Management fully exited Primoris Services in Q1 2025, selling an estimated $7.16M.
  • NEOS Investment Management's ten largest holdings make up 34% of its $5.27B portfolio in Q1 2025.
  • NEOS Investment Management opened 34 new positions and closed 25 in Q1 2025.
  • NEOS Investment Management's portfolio value rose 24% quarter-over-quarter to $5.27B.

Based on NEOS Investment Management's 13F filing for Q1 2025, filed 15 May 2025.